Efficacy and safety of the new antiviral agents for the treatment of hepatitis C virus infection in Egyptian renal transplant recipients
ConclusionDAAs were highly efficacious and safely treated genotype-4 HCV-infected KTRs and had no significant adverse effects on graft function/survival.
Source: International Urology and Nephrology - Category: Urology & Nephrology Source Type: research
More News: Egypt Health | Hepatitis | Hepatitis C | Kidney Transplant | Kidney Transplantation | Norvir | Study | Transplant Surgery | Transplants | Urology & Nephrology | Virology